{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:30:41Z","timestamp":1787772641479,"version":"build-2784847793"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To study the clinico-epidemiologic attributes of persons living with HIV\/AIDS on highly active antiretroviral therapy (HAART).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Clinico-epidemiological details, CD4 counts, previous illness and mucocutaneous diseases were studied in 515 persons living with HIV\/AIDS on HAART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The study comprised 250 (48.5%) males and 265 (51.5%) females aged between 10 and 79 (mean 38.9) years. The 196 (38%) males were drivers, staying-alone laborers\/self-employed, and 253 (49.1%) females were homemakers. All were on HAART for one month to 9 years. Heterosexual transmission was noted in 478 (92.8%) individuals. The 274 (53.5%) individuals had 200\u2013350 CD4 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      counts, whereas it was &lt;200 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      in 88 (17.2%) individuals. Candidiasis (in 48), dermatophytoses (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 23), herpes labialis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 13), herpes zoster (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 12), seborrheic dermatitis (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 29), generalized pruritus (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 22), and xerosis in 20 individuals were the most common dermatoses. Most dermatoses occurred with 200\u2013350 CD4 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      . Adverse drug reactions from antiretroviral therapy (ART) and concurrent therapies also occurred.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Although most of our patients had mild HIV-associated dermatoses while on HAART, adverse drug reactions from HAART or concurrent therapies themselves remain a potential risk. Nevertheless, knowledge of these aspects will help planning for comprehensive health care envisaged in the National AIDS Control Program phase IV.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijd.ijd_543_21","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T17:19:28Z","timestamp":1724951968000},"page":"205","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Clinico-Epidemiologic Attributes of 515 Persons Living With Human Immunodeficiency Virus Infection\/Acquired Immunodeficiency Syndrome on Antiretroviral Therapy"],"prefix":"10.4103","volume":"67","author":[{"given":"Vikram K.","family":"Mahajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mrinal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajni","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TN","family":"Shiny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rattan S.","family":"Rashpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R3-40-20240829","first-page":"82","article-title":"Mucocutaneous manifestations of HIV infection","volume":"70","author":"Shobhana","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R4-40-20240829","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1258\/ijsa.2009.009092","article-title":"Mucocutaneous manifestations in 150 HIV-infected Indian patients and their relationship with CD4 lymphocyte counts","volume":"20","author":"Sud","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R5-40-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0253-7184.112865","article-title":"Pattern of mucocutaneous manifestations in human immunodeficiency virus-positive patients in North India","volume":"34","author":"Kore","year":"2013","journal-title":"Indian J Sex Transm Dis"},{"key":"R6-40-20240829","first-page":"1695","article-title":"Skin and mucocutaneous manifestations: Useful clinical predictors of HIV\/AIDS","volume":"6","author":"Chopra","year":"2012","journal-title":"J Clin Diag Res"},{"key":"R7-40-20240829","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1365-4632.2004.02067.x","article-title":"Skin disease: Clinical indicator of immune status in human immunodeficiency virus (HIV) infection","volume":"44","author":"Raju","year":"2005","journal-title":"Int J Dermatol"},{"key":"R8-40-20240829","doi-asserted-by":"crossref","first-page":"338","DOI":"10.4103\/0019-5154.57609","article-title":"Dermatological manifestations in HIV-infected patients in a tribal (Bastar) region of Chhattisgarh, India","volume":"54","author":"Singh","year":"2009","journal-title":"Indian J Dermatol"},{"key":"R9-40-20240829","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2007.03349.x","article-title":"Correlation of mucocutaneous manifestations of HIV\/AIDS infection with CD4 counts and disease progression","volume":"46","author":"Nnoruka","year":"2007","journal-title":"Int J Dermatol"},{"key":"R11-40-20240829","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4103\/0378-6323.191134","article-title":"Guidelines for the management of Stevens\u2013 Johnson syndrome\/toxic epidermal necrolysis: An Indian perspective","volume":"82","author":"Gupta","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R12-40-20240829","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4103\/0253-7184.185500","article-title":"Knowledge, attitude, and perception of disease among persons living with human immunodeficiency virus\/acquired immuno deficiency syndrome: A study from a tertiary care center in North India","volume":"37","author":"Gupta","year":"2016","journal-title":"Indian J Sex Transm Dis"},{"key":"R13-40-20240829","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.4103\/0976-3147.196451","article-title":"Prevalence of cognitive impairment among persons of rural background living with human immunodeficiency virus infection\/acquired immunodeficiency syndrome on antiretroviral therapy: A study from a tertiary care centre of North India","volume":"7","author":"Mahajan","year":"2016","journal-title":"J Neurosci Rural Pract"},{"key":"R14-40-20240829","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0253-7184.35706","article-title":"Noninfectious cutaneous manifestations of HIV\/AIDS","volume":"28","author":"Sharma","year":"2007","journal-title":"Indian J Sex Transm Dis"},{"key":"R15-40-20240829","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1365-4632.2004.02529.x","article-title":"Patterns of skin manifestations and their relationships with CD4 counts among HIV\/AIDS patients in Cameroon","volume":"45","author":"Josephine","year":"2006","journal-title":"Int J Dermatol"},{"key":"R16-40-20240829","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(99)70082-4","article-title":"Non genital dermatologic diseases in HIV-infected women","volume":"40","author":"Barton","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"R17-40-20240829","first-page":"E33","article-title":"Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population","volume":"11","author":"Bravo","year":"2006","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R18-40-20240829","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1365-2230.2007.02392.x","article-title":"Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: Particular aspects in a Latin-American population","volume":"32","author":"Cunha","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"R19-40-20240829","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-4362.1999.00644.x","article-title":"Mucocutaneous manifestations of HIV infection: A retrospective analysis of 145 cases in a Chinese population in Malaysia","volume":"38","author":"Jing","year":"1999","journal-title":"Int J Dermatol"},{"key":"R20-40-20240829","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0190-9622(87)70066-8","article-title":"Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS)","volume":"16","author":"Kaplan","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"R21-40-20240829","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1034\/j.1398-9995.1999.00885.x","article-title":"Intractable pruritus in HIV infection: Immunologic characterization","volume":"54","author":"Milazzo","year":"1999","journal-title":"Allergy"},{"key":"R22-40-20240829","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1046\/j.1523-1747.1999.00508.x","article-title":"Depletion of cutaneous peptidergic innervation in HIV-associated xerosis","volume":"112","author":"Rowe","year":"1999","journal-title":"J Invest Dermatol"},{"key":"R23-40-20240829","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1468-3083.2011.04429.x","article-title":"Mucocutaneous manifestations of HIV-infected patients in the era of HAART in Guangxi Zhuang Autonomous Region, China","volume":"27","author":"Han","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R24-40-20240829","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/0378-6323.16623","article-title":"Beh\u00e7et's disease with HIV infection: Response to antiretroviral therapy","volume":"71","author":"Mahajan","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"}],"container-title":["Indian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_543_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:07:11Z","timestamp":1787771231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijd.ijd_543_21"}},"subtitle":["A Cross-Sectional Study from a Tertiary Care Centre of North India"],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijd.ijd_543_21","relation":{},"ISSN":["0019-5154"],"issn-type":[{"value":"0019-5154","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}